Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Different Onset Times of Treatment With Pulsed Dye Laser on Improvement of Surgical Scars
This study has been withdrawn prior to recruitment.
( Because of unsatisfactory results of previous trial which assessed the effect of different intervals of PDL on surgical scars. )
First Received: July 23, 2007   Last Updated: November 15, 2008   History of Changes
Sponsored by: Tehran University of Medical Sciences
Information provided by: Tehran University of Medical Sciences
ClinicalTrials.gov Identifier: NCT00506363
  Purpose

The appearance of skin after surgery plays an important role in patient's self confidence and life style. In fact, Keloids and hypertrophic scars are abnormal wound responses appearing in predisposed individuals after surgery. Among different kind of lasers, used to improve the appearance of hypertrophic scars and keloids, pulsed dye laser is now being used successfully in treatment of scars. Pulsed dye laser is effective in improving the color, height, texture, and elasticity of scars. Also, treatment with this technique is noninvasive, minimally uncomfortable, and requires no anesthesia.

This study will assess the efficacy and safety of different onset times of treatment with pulsed dye laser on improvement of surgical scars.


Condition Intervention
Scar
Procedure: pulsed dye laser therapy

Study Type: Interventional
Study Design: Prevention, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Factorial Assignment, Safety/Efficacy Study
Official Title: The Effect of Different Onset Times of Treatment With 595-nm Pulsed Dye Laser on Improvement of Surgical Scars: A Double Blind Randomised Clinical Trial

Resource links provided by NLM:


Further study details as provided by Tehran University of Medical Sciences:

Primary Outcome Measures:
  • pigmentation, pliability, width and height of surgical scars [ Time Frame: baseline, middle of the study, 1 and 3 months after the last treatment session ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • 1- Clinical appearance of scar 2- Patient's satisfaction (scar erythema, scar thickness and scar induration) - Adverse events [ Time Frame: 1 and 3 months after the last treatment session ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 15
Study Start Date: January 2008
Estimated Study Completion Date: May 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
A: Experimental
pulsed dye laser and dynamic cooling device on the day of suture removal
Procedure: pulsed dye laser therapy
Each scar will be divided into 3 equal parts. One part will be randomly allocated to be treated with pulsed dye laser and dynamic cooling device on the day of suture removal. Another part will be treated with pulsed dye laser and dynamic cooling device 2 months after suture removal. Only dynamic cooling device will be used for remaining part serving as control. Treatment will repeat for 6 sessions at 3 weeks intervals.
B: Active Comparator
pulsed dye laser and dynamic cooling device 2 months after suture removal
Procedure: pulsed dye laser therapy
Each scar will be divided into 3 equal parts. One part will be randomly allocated to be treated with pulsed dye laser and dynamic cooling device on the day of suture removal. Another part will be treated with pulsed dye laser and dynamic cooling device 2 months after suture removal. Only dynamic cooling device will be used for remaining part serving as control. Treatment will repeat for 6 sessions at 3 weeks intervals.
C: Sham Comparator
dynamic cooling device
Procedure: pulsed dye laser therapy
Each scar will be divided into 3 equal parts. One part will be randomly allocated to be treated with pulsed dye laser and dynamic cooling device on the day of suture removal. Another part will be treated with pulsed dye laser and dynamic cooling device 2 months after suture removal. Only dynamic cooling device will be used for remaining part serving as control. Treatment will repeat for 6 sessions at 3 weeks intervals.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Surgical scar with minimum length of 6 cm

Exclusion Criteria:

  • History of light sensitivity or photodermatoses
  • History of adverse reactions to laser treatment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00506363

Locations
Iran, Islamic Republic of
Center for research and training in skin diseases and leprosy
Tehran, Iran, Islamic Republic of, 14166
Sponsors and Collaborators
Tehran University of Medical Sciences
Investigators
Principal Investigator: Alireza Firooz, MD Tehran University of Medical Sciences
  More Information

Publications:
Responsible Party: Tehran University of Medical Sciences ( Center for research and training in skin diseases and leprosy )
Study ID Numbers: 423/2224-B
Study First Received: July 23, 2007
Last Updated: November 15, 2008
ClinicalTrials.gov Identifier: NCT00506363     History of Changes
Health Authority: Iran: Ministry of Health

Keywords provided by Tehran University of Medical Sciences:
scar
surgery
lasers

Study placed in the following topic categories:
Skin Diseases
Cicatrix

Additional relevant MeSH terms:
Skin Diseases
Cicatrix

ClinicalTrials.gov processed this record on July 02, 2009